| 000 | 01144 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513184255.0 | ||
| 264 | 0 | _c19990729 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a0192-6233 | ||
| 024 | 7 |
_a10.1177/019262339902700106 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSerabian, M A | |
| 245 | 0 | 0 |
_aSafety assessment of biotechnology-derived pharmaceuticals: ICH and beyond. _h[electronic resource] |
| 260 |
_bToxicologic pathology _c |
||
| 300 |
_a27-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiological Products _xtoxicity |
| 650 | 0 | 4 |
_aBiotechnology _xmethods |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 | _aDrug and Narcotic Control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Cooperation |
| 650 | 0 | 4 | _aInvestigational New Drug Application |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aToxicity Tests _xmethods |
| 700 | 1 | _aPilaro, A M | |
| 773 | 0 |
_tToxicologic pathology _gvol. 27 _gno. 1 _gp. 27-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/019262339902700106 _zAvailable from publisher's website |
| 999 |
_c10326204 _d10326204 |
||